Back
Corporate News
Akums Drugs restricts trading for insiders pending quarterly financial results release
25-Sep-2026, 05:30
Akums Drugs and Pharmaceuticals Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending September 30, 2026, in compliance with SEBI regulations.
